Disease | multiple endocrine neoplasia type 1 |
Comorbidity | C0026986|myelodysplastic syndromes |
Sentences | 1 |
PubMedID- 22781297 | Objective: to evaluate the efficacies and toxicity of hag (hht + ara-c + g-csf) regimen in patients with high-risk myelodysplastic syndromes (mds). |
Page: 1